Spinal Cord Injury clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Delivery Device for Administering LCTOPC1 in Participants with Spinal Cord Injury
Sorry, not yet accepting patients
The DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a spinal cord injury (SCI). LCTOPC1 is designed to replace or support cells that are absent or dysfunctional due to traumatic injury, with a goal to help improve the quality of life and restore or augment functional activity in persons suffering from a traumatic cervical or thoracic injuries.
La Jolla, California
Last updated: